AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
* Skylight Health Group Inc is expected to show a rise in quarterly revenue when it reports results on November 16. * The Mississauga Ontario-based company is expected to report a 49.8% increase in revenue to C$18.274 million from C$12.2 million a year ago, according to the mean estimate from 3 analysts, based on Refinitiv data. * Refinitiv's mean analyst estimate for Skylight Health Group Inc is for a loss of 15 cents per share. * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." * The mean earnings estimate of analysts was unchanged in the last three months. * Wall Street's median 12-month price target for Skylight Health Group Inc is C$2, above its last closing price of C$0.65. Previous quarterly performance (using preferred earnings measure in Canadian dollars). QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI ENDING ARTESTIMAT IBES MET, SE % E® ESTIMATE MISSED Jun. 30 2022 -0.19 -0.19 -0.13 Beat 30.7 Mar. 31 2022 -0.19 -0.17 -0.21 Missed -23.5 Dec. 31 2021 -0.13 -0.12 -0.09 Beat 27.4 Sep. 30 2021 -0.09 -0.09 -0.09 Met -4.7 Jun. -0.06 -0.06 -0.11 Missed -91.3 30 2021 Mar. 31 2021 -0.08 -0.05 -0.06 Missed -20 Dec. 31 2020 0.00 -0.02 -0.30 Missed -1,701 .8 Sep. 30 2020 -0.05 -0.05 -0.05 Met 0 This summary was machine generated November 12 at 01:44 GMT. All figures in Canadian dollars unless otherwise stated.
